Arrowhead Pharmaceuticals, Inc. (ARWR): R&D Expense
$739.14M
Year ended 2026-09-30
+27.9%
3-year compound annual growth
+29.1%
5-year compound annual growth
+28.1%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2026-09-30 | $739.14M | +21.7% | 2026-11-12, From 2025-10-01 |
| 2025-09-30 | $607.16M | +20.0% | 2026-11-12, From 2024-10-01 |
| 2024-09-30 | $505.87M | +43.2% | 2026-11-12, From 2023-10-01 |
| 2023-09-30 | $353.19M | +18.8% | 2025-11-25, From 2022-10-01 |
| 2022-09-30 | $297.31M | +44.1% | 2024-11-26, From 2021-10-01 |
| 2021-09-30 | $206.34M | +60.1% | 2023-11-29, From 2020-10-01 |
| 2020-09-30 | $128.88M | +59.0% | 2022-11-28, From 2019-10-01 |
| 2019-09-30 | $81.05M | +53.0% | 2021-11-22, From 2018-10-01 |
| 2018-09-30 | $52.97M | +4.1% | 2020-11-23, From 2017-10-01 |
| 2017-09-30 | $50.90M | -18.1% | 2019-11-25, From 2016-10-01 |
| 2016-09-30 | $62.12M | +31.4% | 2018-12-11, From 2015-10-01 |
| 2015-09-30 | $47.27M | +104.3% | 2015-12-14, From 2014-10-01 |
| 2014-09-30 | $23.14M | +165.8% | 2015-12-14, From 2013-10-01 |
| 2013-09-30 | $8.71M | +61.5% | 2015-12-14, From 2012-10-01 |
| 2012-09-30 | $5.39M | +64.5% | 2014-11-25, From 2011-10-01 |
| 2011-09-30 | $3.28M | +518.9% | 2012-12-28, From 2010-10-01 |
| 2010-09-30 | $529.6K | n/a | 2011-12-20, From 2009-10-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2026-09-30 | $739.14M | +21.7% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $220.90M | -5.8% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $1.90M | +11.8% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $206.01M | -5.3% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $30.60M | +124.1% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $71.53M | +36.7% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $451.95M | -10.8% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $186.18M | +32.4% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $216.18M | -20.1% |
Compare ARWR, ZLAB, NATR, TVTX side by side · Screen every company in Pharmaceutical Preparations ↗